Pair Name | Sclareolide, Gemcitabine | ||
Phytochemical Name | Sclareolide (PubChem CID: 929262 ) | ||
Anticancer drug Name | Gemcitabine (PubChem CID: 60750 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Sclareolide, Gemcitabine | |||
Disease Info | [ICD-11: 2C10] | Pancreatic cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | CASP3 | hsa836 |
Up-regulation | Expression | CDH1 | hsa999 | |
Down-regulation | Expression | GLI1 | hsa2735 | |
Up-regulation | Expression | PARP1 | hsa142 | |
Down-regulation | Expression | RRM1 | hsa6240 | |
Up-regulation | Expression | SLC29A1 | hsa2030 | |
Down-regulation | Expression | SNAI2 | hsa6591 | |
Down-regulation | Expression | TWIST1 | hsa7291 | |
In Vitro Model | PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0480 |
AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0152 | |
In Vivo Model | Each BALB/c nude mouse was subcutaneously inoculated with 5×10⁶ Panc-1 or GR-Panc-1 cells in their right and left hind footpads. | |||
Result | Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer |
No. | Title | Href |
---|---|---|
1 | Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer. Mol Med Rep. 2017 Apr;15(4):1461-1470. doi: 10.3892/mmr.2017.6182. | Click |